Complexity to Clarity:
Using Multi-Modal Data To Drive Commercial Success
About this webinar
As the demands of precision medicine grow, the complexity of data often creates barriers to success. In this webinar, the expert speakers focus on a leading multi-modal approach that simplifies this complexity and provides actionable insights.
The expert speaker focuses on how this method helps pharma and biotech teams to uncover multidimensional insights that support smarter commercialization strategies, including how this approach overcomes the complexities typically seen with more traditional claims aggregators enabling you to deliver better patient outcomes.
Register for this webinar today to discover how a unique approach is simplifying complex multi-modal data in precision medicine to deliver actionable insights.
Who should attend
- Brand/Commercial Roles
- Market Insights/Analytics Roles
- Operational Teams/Clinical Delivery teams
- Data Scientists/Analysts
- Biotech/Pharmaceutical
- Clinical research
- Regulatory affairs
What you will learn
- How to move beyond stacking data by adopting a multi-modal approach that delivers deeper, actionable insights
- How leveraging lab and genetic data can transform your strategies, moving beyond traditional claims aggregation
- Commercial success by identifying opportunities to overcome market challenges and the tactics to deploy
Featured Speakers
Scott Phillips
Scott Phillips is the Vice President of Real World Data at Diaceutics, where he leads the strategy, development and adoption of the company’s multi-modal data approach. He partners with a diverse range of clients, including aggregators, marketing agencies, pharmaceutical companies, analytic service providers and marketplaces, to drive innovation and results.
With over 15 years of experience in healthcare product development, strategy consulting, market access and business development, Scott has worked closely with pharma and biotech companies to scale and implement groundbreaking digital solutions.
Prior to joining Diaceutics, Scott served as Vice President of Data Strategy at Komodo Health, where he enhanced data products and launched the Health MapEnhance offering. At COTA, as Vice President of Life Sciences, he guided clients in leveraging real-world data (RWD) to optimize clinical research, accelerate drug development and improve oncology trial design.
During his time at Huma, Scott expanded brand awareness and forged strategic partnerships. He also held roles at CVS Health and began his career as a consultant. Scott holds an MBA from Harvard Business School and a BA from Brown University.
Partner for this event
Diaceutics
At Diaceutics, we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.
DXRX is the world’s first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform-enabled solutions.
Related webinars
More from Diaceutics.
Accelerate Precision Medicine Uptake With Impactful Scientific Engagement
Optimize Your Physician Engagement Strategy: Data-Driven HCP Education in Precision Medicine
Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine
Driving Commercial Success for Precision Medicine: Understand the Market to Maximize Patient Identification and Therapy Adoption